Jane Street Group, LLC Adaptimmune Therapeutics PLC Put Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 16, 2021
BUY
$3.44 - $6.37 $215,688 - $399,399
62,700 Added 202.91%
93,600 $484,000
Q2 2021

Aug 16, 2021
BUY
$3.86 - $5.78 $119,274 - $178,602
30,900 New
30,900 $132,000
Q3 2020

Nov 17, 2020
SELL
$7.66 - $10.78 $166,988 - $235,004
-21,800 Closed
0 $0
Q2 2020

Aug 17, 2020
BUY
$2.58 - $12.1 $56,244 - $263,780
21,800 New
21,800 $218,000

Others Institutions Holding ADAP

# of Institutions
83
Shares Held
150M
Call Options Held
60.8K
Put Options Held
5.8K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $98M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email